GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
Date Action Amount Person Type
Apr 08, 2024 Sell 8 858 Davis Stephen Common Stock
Apr 08, 2024 Sell 17 716 Davis Stephen Common Stock
Apr 08, 2024 Sell 2 568 Teehan Brendan Common Stock
Apr 08, 2024 Sell 1 028 Kihara James Common Stock
Apr 08, 2024 Sell 762 Kihara James Common Stock
Apr 08, 2024 Sell 2 716 Schneyer Mark C. Common Stock
Apr 07, 2024 Buy 1 489 Kihara James Common Stock
Apr 07, 2024 Sell 1 489 Kihara James Restricted Stock Units
Apr 05, 2024 Buy 34 666 Davis Stephen Common Stock
Apr 05, 2024 Sell 34 666 Davis Stephen Restricted Stock Units
Apr 05, 2024 Buy 17 333 Davis Stephen Common Stock
Apr 05, 2024 Sell 17 333 Davis Stephen Restricted Stock Units
Apr 05, 2024 Buy 5 024 Teehan Brendan Common Stock
Apr 05, 2024 Sell 5 024 Teehan Brendan Restricted Stock Units
Apr 05, 2024 Buy 2 010 Kihara James Common Stock
Apr 05, 2024 Sell 2 010 Kihara James Restricted Stock Units
Apr 05, 2024 Buy 5 275 Schneyer Mark C. Common Stock
Apr 05, 2024 Sell 5 275 Schneyer Mark C. Restricted Stock Units
Apr 04, 2024 Buy 0 Thompson Elizabeth H.z.
Mar 27, 2024 Sell 5 140 Teehan Brendan Common Stock
Mar 27, 2024 Sell 17 714 Davis Stephen Common Stock
Mar 27, 2024 Sell 5 434 Schneyer Mark C. Common Stock
Mar 25, 2024 Buy 13 964 Kihara James Stock Options (Right to Buy)
Mar 25, 2024 Buy 8 568 Kihara James Restricted Stock Units
Mar 25, 2024 Buy 89 516 Teehan Brendan Stock Options (Right to Buy)
Mar 25, 2024 Buy 10 048 Teehan Brendan Common Stock
Mar 25, 2024 Buy 27 460 Teehan Brendan Restricted Stock Units
Mar 25, 2024 Buy 286 451 Davis Stephen Stock Option (Right to Buy)
Mar 25, 2024 Buy 34 666 Davis Stephen Common Stock
Mar 25, 2024 Buy 80 564 Schneyer Mark C. Stock Options (Right to Buy)
Mar 25, 2024 Buy 10 550 Schneyer Mark C. Common Stock
Mar 25, 2024 Buy 24 714 Schneyer Mark C. Restricted Stock Units
Feb 26, 2024 Sell 772 Schneyer Mark C. Common Stock
Feb 26, 2024 Sell 624 Teehan Brendan Common Stock
Feb 26, 2024 Sell 474 Kihara James Common Stock
Feb 26, 2024 Sell 5 577 Davis Stephen Common Stock
Feb 23, 2024 Buy 1 353 Schneyer Mark C. Common Stock
Feb 23, 2024 Sell 1 353 Schneyer Mark C. Restricted Stock Units
Feb 23, 2024 Buy 1 107 Teehan Brendan Common Stock
Feb 23, 2024 Sell 1 107 Teehan Brendan Restricted Stock Units
Feb 23, 2024 Buy 840 Kihara James Common Stock
Feb 23, 2024 Sell 840 Kihara James Restricted Stock Units
Feb 23, 2024 Buy 10 946 Davis Stephen Common Stock
Feb 23, 2024 Sell 10 946 Davis Stephen Restricted Stock Units
Feb 06, 2024 Buy 126 589 Rhodes Jennifer J Stock Option (Right to Buy)
Feb 06, 2024 Buy 25 889 Rhodes Jennifer J Restricted Stock Units
Feb 06, 2024 Buy 0 Rhodes Jennifer J
Jan 08, 2024 Sell 3 732 Davis Stephen Common Stock
Jan 08, 2024 Sell 731 Teehan Brendan Common Stock
Jan 08, 2024 Sell 590 Kim Austin D. Common Stock
Jan 06, 2024 Buy 9 528 Davis Stephen Common Stock
Jan 06, 2024 Sell 9 528 Davis Stephen Restricted Stock Units
Jan 06, 2024 Buy 1 287 Teehan Brendan Common Stock
Jan 06, 2024 Sell 1 287 Teehan Brendan Restricted Stock Units
Jan 06, 2024 Buy 1 634 Kim Austin D. Common Stock
Jan 06, 2024 Sell 1 634 Kim Austin D. Restricted Stock Units
Dec 15, 2023 Sell 2 000 Kihara James Common Stock
Nov 24, 2023 Sell 2 918 Garofalo Elizabeth A. Common Stock
Nov 20, 2023 Sell 4 960 Teehan Brendan Common Stock
Nov 20, 2023 Sell 5 108 Schneyer Mark C. Common Stock
Nov 20, 2023 Sell 1 985 Kihara James Common Stock
Nov 17, 2023 Buy 4 956 Teehan Brendan Common Stock
Nov 17, 2023 Buy 4 956 Teehan Brendan Common Stock
Nov 17, 2023 Sell 4 956 Teehan Brendan Restricted Stock Units
Nov 17, 2023 Buy 4 956 Schneyer Mark C. Common Stock
Nov 17, 2023 Buy 4 956 Schneyer Mark C. Common Stock
Nov 17, 2023 Sell 4 956 Schneyer Mark C. Restricted Stock Units
Nov 17, 2023 Buy 1 982 Kihara James Common Stock
Nov 17, 2023 Buy 1 982 Kihara James Common Stock
Nov 17, 2023 Sell 1 982 Kihara James Restricted Stock Units
Oct 12, 2023 Buy 4 381 Ndu Adora Common Stock
Oct 12, 2023 Sell 4 381 Ndu Adora Restricted Stock Units
Oct 06, 2023 Sell 16 369 Kim Austin D. Common Stock
Oct 06, 2023 Sell 103 999 Davis Stephen Restricted Stock Units
Oct 06, 2023 Sell 51 563 Davis Stephen Common Stock
Oct 05, 2023 Buy 36 174 Kim Austin D. Common Stock
Oct 05, 2023 Sell 36 174 Kim Austin D. Restricted Stock Units
Oct 05, 2023 Buy 103 999 Davis Stephen Common Stock
Sep 15, 2023 Sell 2 000 Kihara James Common Stock
Aug 21, 2023 Sell 10 000 Schneyer Mark C. Common Stock
Jul 14, 2023 Sell 100 000 Davis Stephen Stock Option (Right to Buy)
Jul 14, 2023 Buy 100 000 Davis Stephen Common Stock
Jul 14, 2023 Sell 100 000 Davis Stephen Common Stock
Jul 12, 2023 Sell 55 104 Davis Stephen Common Stock
Jul 11, 2023 Sell 16 498 Davis Stephen Common Stock
Jun 15, 2023 Sell 2 000 Kihara James Common Stock
Jun 12, 2023 Sell 4 500 Brege Laura Common Stock
Jun 08, 2023 Buy 1 893 Schneyer Mark C. Common Stock
Jun 08, 2023 Sell 974 Schneyer Mark C. Common Stock
Jun 08, 2023 Sell 1 893 Schneyer Mark C. Restricted Stock Units
Jun 01, 2023 Buy 8 552 Soland Daniel B Common Stock
Jun 01, 2023 Buy 11 045 Soland Daniel B Director Stock Options (Right to Buy)
Jun 01, 2023 Buy 6 652 Soland Daniel B Restricted Stock Units
Jun 01, 2023 Sell 8 552 Soland Daniel B Restricted Stock Units
Jun 01, 2023 Buy 11 045 Ndu Adora Director Stock Options (Right to Buy)
Jun 01, 2023 Buy 6 652 Ndu Adora Restricted Stock Units
Jun 01, 2023 Buy 8 552 Brege Laura Common Stock
Jun 01, 2023 Buy 11 045 Brege Laura Director Stock Options (Right to Buy)
Jun 07, 2022 Buy 6 391 Soland Daniel B Common Stock
Jun 22, 2021 Buy 3 059 Soland Daniel B Common Stock
INSIDER POWER
31.194
Last 100 transactions
Buy: 1 174 699 | Sell: 709 800 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 31.194.

In total, the insiders bought 1 174 699 and sold 709 800 ACAD shares in the last 100 trades.

Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT